Who invested in Breye Therapeutics?
Breye Therapeutics's investors include Novo Holdings, BioInnovation Institute, The Danish Growth Fund, Export and Investment Fund and Innovestor, and 9 more on record.
Denmark · Series A startup
2 rounds we have observed, with the 14 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 2 months ago
Funding summaryUpdated 26 Oct 2026
$81Mraised across 2 rounds since 2022, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Breye Therapeutics's investors include Novo Holdings, BioInnovation Institute, The Danish Growth Fund, Export and Investment Fund and Innovestor, and 9 more on record.
Breye Therapeutics has raised $81M across 2 rounds since 2022.
Breye Therapeutics's most recent round was a Series A of $77M in Sept 2026.
Its most recent round, $77M in Sept 2026, is also its largest on record.
Breye Therapeutics's first round on record, in Nov 2022, was backed by Novo Holdings, The Danish Growth Fund and BioInnovation Institute and 1 others.
Breye Therapeutics's latest named round is a Series A, in Sept 2026.
Breye Therapeutics is based in Denmark.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.